BUTALBITAL AND ACETAMINOPHEN TABLETS

BUTALBITAL AND ACETAMINOPHEN TABLETS was reported 606 times

BUTALBITAL AND ACETAMINOPHEN TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IRON BINDING CAPACITY UNSATURATED DECREASED 1 0.0500
1 METASTASES TO URINARY TRACT 1 0.0303
2 GRIP STRENGTH 5 0.0218
3 URETERAL STENT REMOVAL 1 0.0204
4 KIDNEY ANGIOMYOLIPOMA 1 0.0200
5 PERIHEPATIC DISCOMFORT 1 0.0115
6 ADMINISTRATION SITE INFECTION 1 0.0105
7 LARYNGITIS VIRAL 1 0.0094
8 INFUSION SITE HYPERSENSITIVITY 1 0.0083
9 FEMOROACETABULAR IMPINGEMENT 1 0.0081
10 SPLINTER HAEMORRHAGES 1 0.0073
11 PINEAL GLAND CYST 1 0.0071
12 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 4 0.0071
13 SINOBRONCHITIS 1 0.0067
14 CAST APPLICATION 1 0.0064
15 CATHETER SITE WARMTH 1 0.0061
16 RENAL VEIN THROMBOSIS 4 0.0059
17 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 3 0.0057
18 CATHETER SITE INDURATION 1 0.0052
19 ANTIPHOSPHOLIPID ANTIBODIES 1 0.0051
20 STENT MALFUNCTION 1 0.0051
21 SHOULDER DEFORMITY 1 0.0051
22 OCULAR ROSACEA 1 0.0049
23 IRON BINDING CAPACITY TOTAL DECREASED 1 0.0045
24 STOMA SITE DISCOMFORT 1 0.0044
25 C-REACTIVE PROTEIN 4 0.0043
26 CERVICAL RADICULOPATHY 3 0.0042
27 SWOLLEN JOINT COUNT 1 0.0040
28 DEEP VEIN THROMBOSIS POSTOPERATIVE 8 0.0040
29 LUPUS VULGARIS 5 0.0040
30 INGUINAL MASS 1 0.0039
31 SWOLLEN JOINT COUNT INCREASED 12 0.0038
32 GASTROINTESTINAL PROCEDURAL COMPLICATION 1 0.0037
33 FACET JOINT SYNDROME 12 0.0037
34 METASTASES TO BLADDER 1 0.0035
35 DISLOCATION OF VERTEBRA 8 0.0035
36 WHITE BLOOD CELL COUNT 1 0.0034
37 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
38 BREAST CELLULITIS 1 0.0032
39 RENAL SURGERY 2 0.0031
40 ILEECTOMY 1 0.0030
41 TRANSFERRIN SATURATION INCREASED 1 0.0029
42 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 6 0.0029
43 RETINITIS 5 0.0029
44 TENOPLASTY 1 0.0029
45 URETERAL STENT INSERTION 1 0.0029
46 CIRCUMORAL OEDEMA 1 0.0029
47 TRIGEMINAL NERVE DISORDER 1 0.0029
48 HYPOCHOLESTEROLAEMIA 1 0.0028
49 PORPHYRIA ACUTE 4 0.0028
50 MENISCUS OPERATION 1 0.0028
51 PERIODIC LIMB MOVEMENT DISORDER 1 0.0027
52 MEDIASTINAL MASS 1 0.0026
53 BRONCHIAL HYPERREACTIVITY 3 0.0025
54 RHEUMATIC FEVER 11 0.0025
55 VITAMIN D ABNORMAL 1 0.0024
56 HYPOXIC ENCEPHALOPATHY 1 0.0024
57 NAIL OPERATION 1 0.0024
58 TRANSPLANTATION COMPLICATION 1 0.0024
59 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
60 VERTEBRAL OSTEOPHYTE 1 0.0023
61 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
62 SYSTOLIC HYPERTENSION 1 0.0023
63 TEMPORAL LOBE EPILEPSY 1 0.0023
64 MENINGOENCEPHALITIS HERPETIC 1 0.0022
65 CATHETER SITE RASH 1 0.0022
66 ALLERGY TO PLANTS 1 0.0022
67 DUODENAL ULCER PERFORATION 16 0.0021
68 PULMONARY VASCULAR DISORDER 1 0.0021
69 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 1 0.0020
70 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 13 0.0020
71 INFUSION SITE DISCOMFORT 2 0.0019
72 AXILLARY MASS 2 0.0019
73 PULMONARY FUNCTION TEST ABNORMAL 3 0.0019
74 CYST REMOVAL 1 0.0019
75 RHEUMATOID FACTOR POSITIVE 11 0.0019
76 URTICARIAL VASCULITIS 1 0.0019
77 OCCIPITAL NEURALGIA 1 0.0018
78 EUSTACHIAN TUBE DYSFUNCTION 1 0.0017
79 C-REACTIVE PROTEIN ABNORMAL 11 0.0017
80 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
81 X-RAY ABNORMAL 3 0.0017
82 CEREBRAL ARTERY EMBOLISM 2 0.0016
83 CHALAZION 1 0.0016
84 HELICOBACTER INFECTION 16 0.0016
85 ALLERGIC OEDEMA 1 0.0015
86 INTRACRANIAL HYPOTENSION 1 0.0015
87 FOLLICULITIS 16 0.0015
88 INFUSION SITE HAEMORRHAGE 5 0.0015
89 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 1 0.0015
90 INFUSION SITE URTICARIA 1 0.0015
91 PERIPHERAL VENOUS DISEASE 6 0.0015
92 MUSCLE INJURY 12 0.0014
93 DISCHARGE 2 0.0014
94 THERAPEUTIC PROCEDURE 2 0.0014
95 BONE EROSION 5 0.0014
96 FACIAL DISCOMFORT 1 0.0014
97 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 10 0.0014
98 INFUSION SITE REACTION 4 0.0013
99 CATHETER SITE RELATED REACTION 1 0.0013
100 METAPNEUMOVIRUS INFECTION 1 0.0013
101 PRODUCT DROPPER ISSUE 1 0.0013
102 HEAT EXHAUSTION 1 0.0012
103 PANCREATITIS RELAPSING 1 0.0012
104 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
105 SCIATIC NERVE INJURY 1 0.0012
106 INFUSION SITE OEDEMA 1 0.0012
107 LIP PRURITUS 1 0.0012
108 CORONARY ARTERY DISSECTION 1 0.0012
109 ENDOCRINE OPHTHALMOPATHY 1 0.0012
110 CATHETER SITE PRURITUS 1 0.0011
111 TERMINAL INSOMNIA 2 0.0011
112 LIP DRY 10 0.0011
113 HAND DEFORMITY 14 0.0011
114 SCIATICA 17 0.0011
115 BONE MARROW TRANSPLANT 2 0.0011
116 CORRECTIVE LENS USER 1 0.0010
117 DEVICE POWER SOURCE ISSUE 3 0.0010
118 SPINAL LAMINECTOMY 1 0.0010
119 GRIP STRENGTH DECREASED 9 0.0010
120 WOUND INFECTION 11 0.0010
121 EXOSTOSIS 9 0.0010
122 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
123 RENAL MASS 2 0.0010
124 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
125 PEMPHIGUS 12 0.0010
126 LIVE BIRTH 8 0.0010
127 LATENT TUBERCULOSIS 2 0.0010
128 ALLERGY TO ANIMAL 1 0.0009
129 CATHETER SITE ERYTHEMA 2 0.0009
130 BREAST CANCER STAGE III 6 0.0009
131 POST PROCEDURAL SWELLING 1 0.0009
132 TINEA INFECTION 1 0.0009
133 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
134 THYROTOXIC CRISIS 1 0.0009
135 SERONEGATIVE ARTHRITIS 1 0.0009
136 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
137 PAROTITIS 1 0.0009
138 NECK SURGERY 2 0.0009
139 INFECTED CYST 1 0.0008
140 SYNOVITIS 15 0.0008
141 PREMATURE RUPTURE OF MEMBRANES 2 0.0008
142 RASH VESICULAR 4 0.0008
143 SPONDYLITIS 3 0.0008
144 BURSITIS 10 0.0008
145 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
146 HAEMATOCRIT ABNORMAL 1 0.0008
147 ALLERGY TO CHEMICALS 1 0.0008
148 PRE-EXISTING CONDITION IMPROVED 5 0.0008
149 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
150 INFUSION SITE SWELLING 5 0.0008
151 FIBROMYALGIA 19 0.0008
152 INFUSION SITE IRRITATION 1 0.0008
153 PERICARDITIS 13 0.0008
154 WALKING AID USER 5 0.0008
155 HERPES OPHTHALMIC 1 0.0008
156 PHARYNGEAL ULCERATION 1 0.0008
157 GASTROENTERITIS NOROVIRUS 1 0.0008
158 IRRITABLE BOWEL SYNDROME 16 0.0007
159 JOINT RANGE OF MOTION DECREASED 10 0.0007
160 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
161 SPINAL FUSION SURGERY 3 0.0007
162 INFUSION SITE RASH 1 0.0007
163 DEATH NEONATAL 1 0.0007
164 AUTOIMMUNE DISORDER 7 0.0007
165 ONYCHOMADESIS 3 0.0007
166 DRUG TOLERANCE DECREASED 2 0.0007
167 INFUSION SITE ERYTHEMA 6 0.0007
168 BLOOD ELECTROLYTES DECREASED 1 0.0007
169 NOROVIRUS INFECTION 1 0.0007
170 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
171 NECK INJURY 2 0.0007
172 ANKLE OPERATION 1 0.0007
173 INFUSION SITE INDURATION 1 0.0007
174 CRANIOCEREBRAL INJURY 2 0.0007
175 EYE INJURY 2 0.0007
176 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
177 SYNOVIAL CYST 3 0.0006
178 DIASTOLIC DYSFUNCTION 2 0.0006
179 JOINT DESTRUCTION 1 0.0006
180 BLEPHAROSPASM 4 0.0006
181 FOOT DEFORMITY 7 0.0006
182 GLOSSODYNIA 14 0.0006
183 BREATH SOUNDS ABNORMAL 3 0.0006
184 PAPILLOMA VIRAL INFECTION 1 0.0006
185 EDUCATIONAL PROBLEM 1 0.0006
186 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
187 TONGUE ULCERATION 2 0.0006
188 SPLEEN DISORDER 1 0.0006
189 EROSIVE OESOPHAGITIS 1 0.0006
190 SKIN WOUND 1 0.0006
191 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
192 PUSTULAR PSORIASIS 2 0.0006
193 RECALLED PRODUCT 1 0.0006
194 WOUND 16 0.0006
195 LACK OF INJECTION SITE ROTATION 1 0.0006
196 INFUSION SITE DISCHARGE 1 0.0006
197 FANCONI SYNDROME ACQUIRED 1 0.0006
198 HANGOVER 2 0.0006
199 PRESCRIBED OVERDOSE 11 0.0006
200 BREAST CYST 1 0.0006
201 ESSENTIAL HYPERTENSION 1 0.0005
202 INFUSION SITE PAIN 7 0.0005
203 CATHETER PLACEMENT 1 0.0005
204 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
205 PANCREATIC CYST 1 0.0005
206 ADRENAL DISORDER 1 0.0005
207 HYPERCHOLESTEROLAEMIA 5 0.0005
208 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
209 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
210 LIPIDS INCREASED 1 0.0005
211 GOITRE 2 0.0005
212 HYPERPARATHYROIDISM 1 0.0005
213 CHEST INJURY 1 0.0005
214 SKIN INDURATION 1 0.0005
215 BREAST CANCER STAGE II 4 0.0005
216 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
217 PHYSICAL ASSAULT 1 0.0005
218 ANAEMIA MACROCYTIC 1 0.0005
219 LOWER LIMB FRACTURE 9 0.0005
220 INFUSION SITE BRUISING 1 0.0005
221 EAR PAIN 9 0.0005
222 RENAL TUBULAR ACIDOSIS 1 0.0005
223 SOMNAMBULISM 3 0.0005
224 HIP ARTHROPLASTY 7 0.0005
225 IMPAIRED HEALING 15 0.0005
226 CALCINOSIS 1 0.0004
227 MYOSITIS 4 0.0004
228 TYPE 2 DIABETES MELLITUS 15 0.0004
229 APPLICATION SITE URTICARIA 1 0.0004
230 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
231 ULCER HAEMORRHAGE 3 0.0004
232 BRAIN OPERATION 1 0.0004
233 PRODUCT DISTRIBUTION ISSUE 4 0.0004
234 HEPATIC CIRRHOSIS 8 0.0004
235 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
236 PSORIATIC ARTHROPATHY 17 0.0004
237 ROAD TRAFFIC ACCIDENT 17 0.0004
238 DISABILITY 8 0.0004
239 DEVICE INFUSION ISSUE 1 0.0004
240 PREGNANCY 8 0.0004
241 OSTEITIS 1 0.0004
242 TUBERCULIN TEST POSITIVE 1 0.0004
243 RESTLESS LEGS SYNDROME 7 0.0004
244 MULTIPLE ALLERGIES 3 0.0004
245 TRICUSPID VALVE INCOMPETENCE 3 0.0004
246 MIGRAINE 36 0.0004
247 OBESITY 6 0.0004
248 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
249 PROTEIN TOTAL INCREASED 1 0.0004
250 ANIMAL BITE 1 0.0004
251 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
252 PHARYNGITIS STREPTOCOCCAL 4 0.0004
253 LARGE INTESTINAL ULCER 1 0.0004
254 NORMAL NEWBORN 2 0.0004
255 IMPAIRED GASTRIC EMPTYING 5 0.0004
256 LIVER INJURY 9 0.0004
257 CLUMSINESS 1 0.0004
258 ORAL FUNGAL INFECTION 1 0.0004
259 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
260 NECK MASS 1 0.0004
261 HEART VALVE INCOMPETENCE 1 0.0003
262 NEOPLASM 4 0.0003
263 IMPAIRED QUALITY OF LIFE 5 0.0003
264 VITAMIN B12 DECREASED 1 0.0003
265 METASTASES TO LUNG 4 0.0003
266 TASTE DISORDER 7 0.0003
267 NAIL DISORDER 3 0.0003
268 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
269 DECREASED INTEREST 2 0.0003
270 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
271 ANAL INCONTINENCE 3 0.0003
272 LUPUS-LIKE SYNDROME 3 0.0003
273 DISCOMFORT 20 0.0003
274 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
275 POISONING 4 0.0003
276 INFUSION SITE PRURITUS 1 0.0003
277 NON-CARDIAC CHEST PAIN 1 0.0003
278 PULMONARY FIBROSIS 6 0.0003
279 ATELECTASIS 3 0.0003
280 NIGHT SWEATS 10 0.0003
281 VITAMIN D DEFICIENCY 3 0.0003
282 OSTEOARTHRITIS 13 0.0003
283 HEPATIC NEOPLASM 1 0.0003
284 COELIAC DISEASE 3 0.0003
285 DEAFNESS NEUROSENSORY 1 0.0003
286 SUSPECTED COVID-19 1 0.0003
287 PRESCRIBED UNDERDOSE 6 0.0003
288 LYME DISEASE 1 0.0003
289 ANXIETY DISORDER 1 0.0003
290 GAIT INABILITY 10 0.0003
291 POST-TRAUMATIC STRESS DISORDER 2 0.0003
292 SLEEP DISORDER 21 0.0003
293 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
294 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
295 EYELID PTOSIS 3 0.0003
296 HEPATIC CYST 1 0.0003
297 BODY TEMPERATURE INCREASED 6 0.0003
298 LIVER DISORDER 13 0.0003
299 EAR DISCOMFORT 3 0.0003
300 OSTEOPOROSIS 12 0.0003
301 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
302 MICTURITION DISORDER 1 0.0003
303 WEIGHT FLUCTUATION 3 0.0003
304 TYPE I HYPERSENSITIVITY 1 0.0003
305 MACULOPATHY 1 0.0003
306 APPENDICECTOMY 1 0.0003
307 SKIN WEEPING 1 0.0003
308 STOMATITIS 17 0.0003
309 DEVICE PLACEMENT ISSUE 1 0.0003
310 SEBORRHOEA 1 0.0003
311 INFUSION RELATED REACTION 18 0.0003
312 INFLAMMATION 14 0.0003
313 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
314 TENDON INJURY 1 0.0003
315 HYPERACUSIS 1 0.0003
316 GENERAL SYMPTOM 2 0.0003
317 AUTOIMMUNE THYROIDITIS 1 0.0003
318 CATHETER SITE INFECTION 1 0.0003
319 PARANASAL SINUS DISCOMFORT 1 0.0003
320 ECONOMIC PROBLEM 4 0.0003
321 FOOT FRACTURE 5 0.0003
322 SINUSITIS 27 0.0003
323 ILL-DEFINED DISORDER 16 0.0003
324 EAR INFECTION 7 0.0003
325 THYROID MASS 1 0.0003
326 CONCUSSION 2 0.0003
327 APHTHOUS ULCER 2 0.0003
328 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
329 FAECES HARD 1 0.0003
330 RHINOVIRUS INFECTION 1 0.0003
331 BRONCHITIS 19 0.0003
332 BRAIN FOG 4 0.0003
333 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
334 HEPATIC ENZYME INCREASED 17 0.0002
335 ENURESIS 1 0.0002
336 NOCTURIA 3 0.0002
337 VITAMIN B12 DEFICIENCY 1 0.0002
338 APPLICATION SITE DISCOLOURATION 1 0.0002
339 BACK DISORDER 4 0.0002
340 THERAPY NON-RESPONDER 11 0.0002
341 MUSCLE SPASTICITY 3 0.0002
342 SPINAL OPERATION 3 0.0002
343 SPINAL STENOSIS 1 0.0002
344 PULMONARY HYPERTENSION 5 0.0002
345 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
346 THROAT CANCER 1 0.0002
347 WHEEZING 14 0.0002
348 RETCHING 5 0.0002
349 INTERVERTEBRAL DISC DISORDER 1 0.0002
350 ARTHROPATHY 13 0.0002
351 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
352 TENSION HEADACHE 1 0.0002
353 TEARFULNESS 1 0.0002
354 PSYCHOLOGICAL TRAUMA 2 0.0002
355 HIATUS HERNIA 3 0.0002
356 HEPATIC LESION 1 0.0002
357 CARDIAC MURMUR 2 0.0002
358 MUSCULOSKELETAL PAIN 12 0.0002
359 DIVERTICULUM INTESTINAL 1 0.0002
360 ANHEDONIA 6 0.0002
361 MELANOCYTIC NAEVUS 1 0.0002
362 ONYCHOMYCOSIS 1 0.0002
363 DRUG INTOLERANCE 22 0.0002
364 SPINAL OSTEOARTHRITIS 2 0.0002
365 ANKYLOSING SPONDYLITIS 3 0.0002
366 CATHETERISATION CARDIAC 1 0.0002
367 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
368 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
369 IMMUNE THROMBOCYTOPENIA 1 0.0002
370 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
371 COORDINATION ABNORMAL 3 0.0002
372 ROSACEA 1 0.0002
373 NEPHROPATHY 2 0.0002
374 BLOOD PROLACTIN INCREASED 1 0.0002
375 SEASONAL ALLERGY 3 0.0002
376 SKIN ABRASION 1 0.0002
377 COLITIS MICROSCOPIC 1 0.0002
378 SARCOIDOSIS 1 0.0002
379 PRE-ECLAMPSIA 1 0.0002
380 ENDOMETRIOSIS 1 0.0002
381 SLEEP APNOEA SYNDROME 4 0.0002
382 MOBILITY DECREASED 15 0.0002
383 LIMB OPERATION 1 0.0002
384 FINGER DEFORMITY 1 0.0002
385 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
386 ASTHMA 23 0.0002
387 KNEE OPERATION 2 0.0002
388 SWELLING 19 0.0002
389 CARDIOMYOPATHY 3 0.0002
390 SPRUE-LIKE ENTEROPATHY 1 0.0002
391 EXPIRED DRUG ADMINISTERED 1 0.0002
392 FOOT OPERATION 1 0.0002
393 DELIRIUM 7 0.0002
394 ABDOMINAL TENDERNESS 1 0.0002
395 IMMUNODEFICIENCY 3 0.0002
396 ANEURYSM 1 0.0002
397 FLUID INTAKE REDUCED 1 0.0002
398 BRAIN INJURY 2 0.0002
399 OSTEOPENIA 3 0.0002
400 DRUG TOLERANCE 1 0.0002
401 TOOTH ABSCESS 2 0.0002
402 WEIGHT LOSS POOR 1 0.0002
403 THYROID DISORDER 3 0.0002
404 VARICOSE VEIN 1 0.0002
405 INFECTION 28 0.0002
406 BLOOD CHOLESTEROL INCREASED 9 0.0002
407 PARTIAL SEIZURES 1 0.0002
408 JOINT STIFFNESS 5 0.0002
409 KNEE ARTHROPLASTY 4 0.0002
410 POLYARTHRITIS 1 0.0002
411 SCRATCH 2 0.0002
412 JOINT DISLOCATION 2 0.0002
413 FULL BLOOD COUNT ABNORMAL 2 0.0002
414 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 9 0.0002
415 FOOD POISONING 1 0.0002
416 DECREASED ACTIVITY 2 0.0002
417 FREQUENT BOWEL MOVEMENTS 5 0.0002
418 DRY MOUTH 15 0.0002
419 SKIN LACERATION 2 0.0002
420 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
421 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
422 JOINT SWELLING 22 0.0002
423 DENTAL CARIES 2 0.0002
424 CYSTIC FIBROSIS 1 0.0002
425 STREPTOCOCCAL INFECTION 1 0.0002
426 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
427 HEART RATE ABNORMAL 1 0.0002
428 SNEEZING 4 0.0002
429 BLISTER 10 0.0002
430 CONTUSION 17 0.0002
431 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
432 DERMATITIS CONTACT 2 0.0002
433 MUSCULOSKELETAL DISCOMFORT 3 0.0002
434 BLOOD URIC ACID INCREASED 1 0.0002
435 METABOLIC DISORDER 1 0.0002
436 PRODUCT LABEL CONFUSION 1 0.0002
437 EOSINOPHILIA 3 0.0002
438 HYPOVOLAEMIA 1 0.0002
439 INJURY 12 0.0002
440 HYPERCHLORHYDRIA 1 0.0002
441 LABORATORY TEST ABNORMAL 5 0.0002
442 PLEURISY 1 0.0002
443 SINUS HEADACHE 1 0.0002
444 GASTROINTESTINAL DISORDER 15 0.0002
445 RHEUMATOID ARTHRITIS 19 0.0002
446 PLATELET COUNT ABNORMAL 1 0.0002
447 ADRENAL INSUFFICIENCY 2 0.0002
448 NEURALGIA 4 0.0002
449 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
450 ABDOMINAL DISCOMFORT 27 0.0002
451 INFUSION SITE EXTRAVASATION 1 0.0002
452 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
453 BONE DENSITY DECREASED 5 0.0002
454 DRUG-INDUCED LIVER INJURY 5 0.0002
455 NASOPHARYNGITIS 29 0.0002
456 FLUID RETENTION 8 0.0002
457 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
458 POST PROCEDURAL COMPLICATION 3 0.0002
459 HAEMOGLOBIN ABNORMAL 1 0.0002
460 HERPES SIMPLEX 1 0.0002
461 BRADYPHRENIA 1 0.0002
462 KIDNEY INFECTION 3 0.0002
463 PRODUCT PREPARATION ISSUE 1 0.0002
464 ORAL CANDIDIASIS 2 0.0002
465 DYSGRAPHIA 1 0.0002
466 MUSCULAR WEAKNESS 17 0.0001
467 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
468 METASTASES TO LYMPH NODES 1 0.0001
469 POSTOPERATIVE WOUND INFECTION 1 0.0001
470 OEDEMA 8 0.0001
471 HYPOAESTHESIA 22 0.0001
472 ECCHYMOSIS 1 0.0001
473 CORONARY ARTERY OCCLUSION 2 0.0001
474 JOINT EFFUSION 1 0.0001
475 TOOTH LOSS 3 0.0001
476 LYMPHOEDEMA 1 0.0001
477 COMPLETED SUICIDE 12 0.0001
478 HYPERTRANSAMINASAEMIA 1 0.0001
479 FORMICATION 1 0.0001
480 EXTRASYSTOLES 1 0.0001
481 PERIPHERAL SWELLING 22 0.0001
482 HYPERTENSION 30 0.0001
483 THERMAL BURN 1 0.0001
484 EATING DISORDER 3 0.0001
485 IMPAIRED WORK ABILITY 3 0.0001
486 PARAESTHESIA ORAL 2 0.0001
487 VISUAL FIELD DEFECT 1 0.0001
488 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
489 INJECTION SITE BRUISING 11 0.0001
490 MUSCULOSKELETAL STIFFNESS 12 0.0001
491 INTENTIONAL UNDERDOSE 1 0.0001
492 MAJOR DEPRESSION 1 0.0001
493 SURGERY 8 0.0001
494 SENSITIVE SKIN 1 0.0001
495 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
496 ARTHROPOD BITE 1 0.0001
497 COLITIS ULCERATIVE 6 0.0001
498 SUNBURN 1 0.0001
499 RESPIRATORY DISORDER 4 0.0001
500 BONE LOSS 2 0.0001
501 PAROSMIA 1 0.0001
502 PANCREATITIS 7 0.0001
503 DEPRESSED MOOD 7 0.0001
504 TROPONIN INCREASED 1 0.0001
505 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
506 EPILEPSY 4 0.0001
507 INSURANCE ISSUE 2 0.0001
508 FOOD ALLERGY 1 0.0001
509 ANKLE FRACTURE 2 0.0001
510 TENDONITIS 2 0.0001
511 HAEMORRHAGIC STROKE 1 0.0001
512 AFFECTIVE DISORDER 1 0.0001
513 HEAD INJURY 4 0.0001
514 DISEASE RECURRENCE 6 0.0001
515 RESPIRATORY TRACT CONGESTION 2 0.0001
516 GINGIVAL PAIN 1 0.0001
517 BLOOD DISORDER 1 0.0001
518 SENSORY DISTURBANCE 2 0.0001
519 RHINITIS 1 0.0001
520 MYASTHENIA GRAVIS 1 0.0001
521 MUSCLE DISORDER 1 0.0001
522 POST PROCEDURAL INFECTION 1 0.0001
523 SUBSTANCE ABUSE 1 0.0001
524 LUNG DISORDER 6 0.0001
525 INJECTION SITE URTICARIA 3 0.0001
526 MULTIPLE FRACTURES 2 0.0001
527 HEADACHE 76 0.0001
528 SECOND PRIMARY MALIGNANCY 1 0.0001
529 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
530 HEPATITIS 3 0.0001
531 PSEUDOMONAS INFECTION 1 0.0001
532 INFLUENZA 13 0.0001
533 BLOOD MAGNESIUM DECREASED 1 0.0001
534 HAEMATOMA 3 0.0001
535 MUSCLE STRAIN 1 0.0001
536 SKIN SWELLING 1 0.0001
537 VERTIGO 7 0.0001
538 GROIN PAIN 1 0.0001
539 IMMUNOSUPPRESSION 1 0.0001
540 LYMPHOCYTE COUNT DECREASED 2 0.0001
541 PAIN 69 0.0001
542 FACIAL PAIN 1 0.0001
543 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
544 WEIGHT INCREASED 25 0.0001
545 GASTROINTESTINAL INFECTION 1 0.0001
546 GOUT 2 0.0001
547 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
548 DISTURBANCE IN ATTENTION 6 0.0001
549 OROPHARYNGEAL DISCOMFORT 1 0.0001
550 TOOTHACHE 2 0.0001
551 BONE DISORDER 2 0.0001
552 GAIT DISTURBANCE 21 0.0001
553 END STAGE RENAL DISEASE 2 0.0001
554 INCREASED TENDENCY TO BRUISE 1 0.0001
555 NERVE COMPRESSION 1 0.0001
556 HYPOKALAEMIA 5 0.0001
557 HEPATIC STEATOSIS 2 0.0001
558 NECK PAIN 6 0.0001
559 MIDDLE INSOMNIA 2 0.0001
560 ALOPECIA 21 0.0001
561 FLANK PAIN 1 0.0001
562 SQUAMOUS CELL CARCINOMA 1 0.0001
563 SPINAL DISORDER 1 0.0001
564 DEPRESSION 24 0.0001
565 CHRONIC KIDNEY DISEASE 8 0.0001
566 PRODUCT PACKAGING ISSUE 1 0.0001
567 MUSCULOSKELETAL DISORDER 2 0.0001
568 MULTIPLE SCLEROSIS 5 0.0001
569 SKIN FISSURES 2 0.0001
570 PHARYNGEAL SWELLING 1 0.0001
571 MEMORY IMPAIRMENT 14 0.0001
572 DYSPEPSIA 10 0.0001
573 HOSPICE CARE 1 0.0001
574 LIGAMENT SPRAIN 1 0.0001
575 EMBEDDED DEVICE 1 0.0001
576 INABILITY TO AFFORD MEDICATION 1 0.0001
577 BURNING SENSATION 7 0.0001
578 BLOOD POTASSIUM DECREASED 3 0.0001
579 PRODUCT PHYSICAL ISSUE 2 0.0001
580 THERAPEUTIC RESPONSE DECREASED 6 0.0001
581 ANXIETY 28 0.0001
582 SLUGGISHNESS 1 0.0001
583 FEELING HOT 6 0.0001
584 INJECTION SITE RASH 3 0.0001
585 INITIAL INSOMNIA 1 0.0001
586 ILLNESS 10 0.0001
587 HYPERSENSITIVITY 18 0.0001
588 LIMB DISCOMFORT 3 0.0001
589 TEMPERATURE INTOLERANCE 1 0.0001
590 VISUAL IMPAIRMENT 12 0.0001
591 SKELETAL INJURY 1 0.0001
592 POOR VENOUS ACCESS 1 0.0001
593 EXPOSURE DURING PREGNANCY 6 0.0001
594 VENTRICULAR EXTRASYSTOLES 1 0.0001
595 EYE DISCHARGE 1 0.0001
596 TENDERNESS 1 0.0001
597 CARDIO-RESPIRATORY ARREST 4 0.0001
598 ECZEMA 5 0.0001
599 INJECTION SITE DISCOMFORT 1 0.0001
600 FATIGUE 74 0.0001
601 MOUTH ULCERATION 2 0.0001
602 RENAL PAIN 1 0.0001
603 INSOMNIA 25 0.0001
604 CHILLS 11 0.0001
605 HIP FRACTURE 3 0.0001
606 HEREDITARY ANGIOEDEMA 1 0.0001
607 LIVER FUNCTION TEST INCREASED 2 0.0001
608 RASH PRURITIC 5 0.0001
609 AMNESIA 6 0.0001
610 BACK INJURY 1 0.0001
611 PSORIASIS 12 0.0001
612 BLOOD PRESSURE INCREASED 14 0.0001
613 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
614 ASPIRATION 1 0.0001
615 HOSPITALISATION 14 0.0001
616 INJECTION SITE NODULE 1 0.0001
617 EMOTIONAL DISTRESS 11 0.0001
618 HEART RATE INCREASED 9 0.0001
619 TOOTH FRACTURE 1 0.0001
620 VIRAL INFECTION 3 0.0001
621 MEDICATION ERROR 5 0.0001
622 TOOTH DISORDER 2 0.0001
623 EYE PRURITUS 3 0.0001
624 RASH PAPULAR 2 0.0001
625 SKIN INFECTION 1 0.0001
626 OCULAR DISCOMFORT 1 0.0001
627 PARAESTHESIA 14 0.0001
628 FISTULA 1 0.0001
629 EYE PAIN 5 0.0001
630 PRURITUS 34 0.0001
631 PRODUCT DOSE OMISSION ISSUE 26 0.0001
632 SCAB 1 0.0001
633 ABDOMINAL PAIN UPPER 18 0.0001
634 GASTRIC DISORDER 3 0.0001
635 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
636 CHEST PAIN 16 0.0001
637 ABDOMINAL DISTENSION 9 0.0001
638 ELECTROLYTE IMBALANCE 1 0.0001
639 POST PROCEDURAL HAEMORRHAGE 1 0.0001
640 SPLENOMEGALY 1 0.0001
641 BONE PAIN 5 0.0001
642 SPINAL PAIN 1 0.0001
643 SEXUAL DYSFUNCTION 1 0.0001
644 INFLUENZA LIKE ILLNESS 7 0.0001
645 LYMPHADENOPATHY 3 0.0001
646 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
647 COVID-19 PNEUMONIA 1 0.0001
648 DYSPHAGIA 8 0.0001
649 BACTERAEMIA 1 0.0001
650 CHOLECYSTITIS 1 0.0001
651 ACCIDENT 1 0.0001
652 MACULAR DEGENERATION 1 0.0001
653 HYPERLIPIDAEMIA 1 0.0001
654 RASH ERYTHEMATOUS 4 0.0001
655 CONSTIPATION 18 0.0001
656 MENTAL IMPAIRMENT 2 0.0001
657 C-REACTIVE PROTEIN INCREASED 3 0.0001
658 MALAISE 36 0.0001
659 NO THERAPEUTIC RESPONSE 1 0.0001
660 CEREBRAL INFARCTION 2 0.0001
661 CYTOPENIA 1 0.0001
662 CARDIOMEGALY 1 0.0001
663 INJECTION SITE EXTRAVASATION 1 0.0001
664 TENDON RUPTURE 1 0.0001
665 GENERALISED OEDEMA 1 0.0001
666 CYST 1 0.0001
667 CONFUSIONAL STATE 13 0.0001
668 APPLICATION SITE IRRITATION 1 0.0001
669 HAIR COLOUR CHANGES 1 0.0001
670 TOOTH EXTRACTION 1 0.0001
671 DRY EYE 4 0.0001
672 SECRETION DISCHARGE 1 0.0001
673 PRODUCT USE ISSUE 15 0.0001
674 HOT FLUSH 6 0.0001
675 CELLULITIS 4 0.0001
676 ARTHRALGIA 33 0.0001
677 UNEVALUABLE EVENT 6 0.0001
678 BRAIN OEDEMA 1 0.0001
679 CONDITION AGGRAVATED 24 0.0001
680 INJECTION SITE IRRITATION 1 0.0001
681 HYPOPHAGIA 2 0.0001
682 ROTATOR CUFF SYNDROME 1 0.0001
683 DYSPNOEA 44 0.0001
684 URTICARIA 13 0.0001
685 ASTHENIA 29 0.0001
686 DIPLOPIA 2 0.0001
687 PRODUCT DOSE OMISSION 5 0.0001
688 MYALGIA 13 0.0001
689 GASTRITIS 2 0.0001
690 ADVERSE EVENT 7 0.0001
691 TOOTH INFECTION 1 0.0001
692 SARS-COV-2 TEST POSITIVE 1 0.0001
693 ADVERSE REACTION 1 0.0001
694 HAIR TEXTURE ABNORMAL 1 0.0001
695 MALIGNANT MELANOMA 1 0.0001
696 NAUSEA 59 0.0001
697 QUALITY OF LIFE DECREASED 1 0.0001
698 THROAT TIGHTNESS 2 0.0001
699 NEUTROPHIL COUNT DECREASED 3 0.0001
700 PALLOR 2 0.0001
701 DRUG TOXICITY 1 0.0001
702 RASH 32 0.0001
703 DECREASED APPETITE 17 0.0001
704 ACUTE HEPATIC FAILURE 1 0.0001
705 BACK PAIN 17 0.0001
706 TREATMENT NONCOMPLIANCE 4 0.0001
707 SKIN LESION 2 0.0001
708 INJECTION SITE REACTION 5 0.0001
709 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
710 TREATMENT FAILURE 6 0.0001
711 VOMITING 34 0.0001
712 FEELING COLD 2 0.0001
713 HUNGER 1 0.0001
714 APHONIA 1 0.0001
715 MASS 1 0.0001
716 PAIN IN EXTREMITY 21 0.0001
717 BLOOD TEST ABNORMAL 1 0.0001
718 FEELING ABNORMAL 17 0.0001
719 BLINDNESS UNILATERAL 1 0.0001
720 INTENTIONAL DOSE OMISSION 2 0.0001
721 HYPERHIDROSIS 9 0.0001
722 PARALYSIS 1 0.0001
723 SUBDURAL HAEMATOMA 1 0.0001
724 HYPERSOMNIA 2 0.0001
725 EYE IRRITATION 4 0.0001
726 MYELODYSPLASTIC SYNDROME 1 0.0001
727 HYPERTHYROIDISM 1 0.0001
728 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
729 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
730 FLUSHING 7 0.0001
731 INTENTIONAL PRODUCT MISUSE 6 0.0001
732 INJECTION SITE PAIN 21 0.0001
733 COVID-19 12 0.0001
734 CHEST DISCOMFORT 7 0.0001
735 DIARRHOEA 44 0.0001
736 NASAL CONGESTION 4 0.0001
737 WEIGHT DECREASED 19 0.0001
738 URINARY INCONTINENCE 2 0.0001
739 SKIN HAEMORRHAGE 1 0.0001
740 RENAL INJURY 2 0.0001
741 PULMONARY MASS 1 0.0001
742 THROAT IRRITATION 3 0.0001
743 IRRITABILITY 4 0.0001
744 DRUG DISPENSING ERROR 1 0.0001
745 NEPHROLITHIASIS 3 0.0001
746 MUSCLE SPASMS 12 0.0001
747 SKIN DISCOLOURATION 3 0.0001
748 DRUG ADMINISTRATION ERROR 2 0.0001
749 PHARYNGEAL OEDEMA 1 0.0001
750 OROPHARYNGEAL PAIN 6 0.0001
751 LYMPHOMA 1 0.0001
752 MUSCULOSKELETAL CHEST PAIN 1 0.0001
753 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
754 SOMNOLENCE 13 0.0001
755 URINARY TRACT INFECTION 11 0.0001
756 BASAL CELL CARCINOMA 1 0.0001
757 SWOLLEN TONGUE 2 0.0001
758 PYREXIA 22 0.0001
759 PRODUCT USE COMPLAINT 1 0.0001
760 PNEUMOTHORAX 1 0.0001
761 HALLUCINATION, AUDITORY 1 0.0001
762 PREMATURE DELIVERY 1 0.0001
763 MUSCLE TIGHTNESS 1 0.0001
764 OSTEONECROSIS 2 0.0001
765 PHOTOSENSITIVITY REACTION 1 0.0001
766 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
767 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
768 FUNGAL INFECTION 2 0.0001
769 LEUKOPENIA 3 0.0001
770 SKIN DISORDER 2 0.0001
771 BLOOD UREA INCREASED 1 0.0001
772 INJECTION SITE PRURITUS 4 0.0001
773 HEMIPARESIS 1 0.0001
774 PNEUMONIA 19 0.0001
775 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
776 BALANCE DISORDER 5 0.0001
777 OEDEMA PERIPHERAL 7 0.0001
778 ORTHOSTATIC HYPOTENSION 1 0.0001
779 SPEECH DISORDER 3 0.0001
780 HEART RATE DECREASED 2 0.0001
781 METASTASES TO LIVER 1 0.0001
782 HEAD DISCOMFORT 1 0.0001
783 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
784 INJECTION SITE ERYTHEMA 7 0.0001
785 TACHYCARDIA 5 0.0001
786 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
787 DIZZINESS 28 0.0001
788 GALLBLADDER DISORDER 1 0.0001
789 CEREBRAL HAEMORRHAGE 2 0.0001
790 ADVERSE DRUG REACTION 5 0.0001
791 GASTROENTERITIS VIRAL 1 0.0001
792 COMPLICATION OF DEVICE REMOVAL 1 0.0001
793 OSTEOMYELITIS 1 0.0001
794 DRUG EFFECT INCOMPLETE 2 0.0001
795 PELVIC PAIN 1 0.0001
796 PANIC ATTACK 2 0.0001
797 ACCIDENTAL OVERDOSE 2 0.0001
798 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
799 BLOOD GLUCOSE ABNORMAL 1 0.0001
800 CONJUNCTIVITIS 1 0.0001
801 THINKING ABNORMAL 1 0.0001
802 BACTERIAL INFECTION 1 0.0001
803 CARDIAC DISORDER 5 0.0001
804 OXYGEN SATURATION DECREASED 3 0.0001
805 PHOTOPHOBIA 1 0.0001
806 BLOOD SODIUM DECREASED 1 0.0001
807 FRACTURE 1 0.0001
808 BLOOD URINE PRESENT 1 0.0001
809 GASTRIC ULCER 1 0.0001
810 PROTEINURIA 1 0.0001
811 DEHYDRATION 7 0.0001
812 FEELING JITTERY 1 0.0001
813 INCREASED APPETITE 1 0.0001
814 HERPES ZOSTER 3 0.0001
815 LETHARGY 3 0.0001
816 GLAUCOMA 1 0.0001
817 HERNIA 1 0.0001
818 ABDOMINAL PAIN 12 0.0001
819 DYSPHONIA 3 0.0001
820 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
821 HAEMORRHOIDS 1 0.0001
822 ORAL HERPES 1 0.0001
823 FALL 17 0.0001
824 VISION BLURRED 7 0.0001
825 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
826 SINUS DISORDER 1 0.0001
827 COMPLICATION OF DEVICE INSERTION 1 0.0001
828 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
829 COUGH 14 0.0000
830 HYPOTENSION 10 0.0000
831 THROMBOSIS 4 0.0000
832 EXTRA DOSE ADMINISTERED 2 0.0000
833 FEEDING DISORDER 1 0.0000
834 RIB FRACTURE 1 0.0000
835 INJECTION SITE WARMTH 1 0.0000
836 POLLAKIURIA 2 0.0000
837 INTENTIONAL DRUG MISUSE 1 0.0000
838 RENAL IMPAIRMENT 4 0.0000
839 SKIN EXFOLIATION 4 0.0000
840 JOINT INJURY 1 0.0000
841 RECTAL HAEMORRHAGE 2 0.0000
842 HYPOACUSIS 2 0.0000
843 POOR QUALITY SLEEP 1 0.0000
844 SKIN CANCER 1 0.0000
845 RHINORRHOEA 3 0.0000
846 DRUG INEFFECTIVE 61 0.0000
847 SWELLING FACE 3 0.0000
848 MENTAL DISORDER 2 0.0000
849 BLOOD CREATININE INCREASED 3 0.0000
850 PRODUCT PRESCRIBING ISSUE 1 0.0000
851 DEVICE DIFFICULT TO USE 3 0.0000
852 BLOOD PRESSURE DECREASED 3 0.0000
853 STEVENS-JOHNSON SYNDROME 1 0.0000
854 DRY SKIN 6 0.0000
855 NEOPLASM MALIGNANT 3 0.0000
856 HEPATOTOXICITY 1 0.0000
857 ORAL PAIN 1 0.0000
858 PANCREATITIS ACUTE 1 0.0000
859 SEIZURE 5 0.0000
860 RENAL DISORDER 2 0.0000
861 COGNITIVE DISORDER 2 0.0000
862 PALPITATIONS 5 0.0000
863 OFF LABEL USE 37 0.0000
864 NEUROPATHY PERIPHERAL 4 0.0000
865 PRODUCT PRESCRIBING ERROR 1 0.0000
866 THERAPY INTERRUPTED 3 0.0000
867 PRODUCTIVE COUGH 2 0.0000
868 BLOOD PRESSURE FLUCTUATION 1 0.0000
869 LOCALISED INFECTION 1 0.0000
870 UNDERDOSE 3 0.0000
871 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
872 EPISTAXIS 3 0.0000
873 SYNCOPE 4 0.0000
874 HAEMATEMESIS 1 0.0000
875 INJECTION SITE SWELLING 3 0.0000
876 LOSS OF CONSCIOUSNESS 5 0.0000
877 EXPOSURE VIA SKIN CONTACT 1 0.0000
878 DEAFNESS 1 0.0000
879 APPLICATION SITE ERYTHEMA 1 0.0000
880 ARTHRITIS 3 0.0000
881 DERMATITIS ATOPIC 2 0.0000
882 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
883 PLATELET COUNT DECREASED 4 0.0000
884 LIMB INJURY 1 0.0000
885 MOOD ALTERED 1 0.0000
886 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
887 DIVERTICULITIS 1 0.0000
888 MENTAL STATUS CHANGES 1 0.0000
889 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
890 HAEMOPTYSIS 1 0.0000
891 PAIN IN JAW 1 0.0000
892 FLATULENCE 2 0.0000
893 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
894 RED BLOOD CELL COUNT DECREASED 1 0.0000
895 ANGINA PECTORIS 1 0.0000
896 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
897 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
898 NEEDLE ISSUE 1 0.0000
899 DYSSTASIA 1 0.0000
900 ERYTHEMA 7 0.0000
901 CATARACT 2 0.0000
902 HEPATIC FAILURE 1 0.0000
903 LACRIMATION INCREASED 1 0.0000
904 CORONARY ARTERY DISEASE 1 0.0000
905 PLEURAL EFFUSION 2 0.0000
906 SUICIDAL IDEATION 3 0.0000
907 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
908 EMOTIONAL DISORDER 1 0.0000
909 NERVOUS SYSTEM DISORDER 1 0.0000
910 ANAEMIA 6 0.0000
911 CYSTITIS 1 0.0000
912 MOVEMENT DISORDER 1 0.0000
913 CHOLELITHIASIS 1 0.0000
914 STAPHYLOCOCCAL INFECTION 1 0.0000
915 EXPIRED PRODUCT ADMINISTERED 1 0.0000
916 LIP SWELLING 1 0.0000
917 TOXICITY TO VARIOUS AGENTS 5 0.0000
918 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
919 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
920 CEREBROVASCULAR ACCIDENT 5 0.0000
921 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
922 NIGHTMARE 1 0.0000
923 DEVICE USE ERROR 1 0.0000
924 NEOPLASM PROGRESSION 1 0.0000
925 HAEMORRHAGE 3 0.0000
926 RASH MACULAR 1 0.0000
927 HYPOXIA 1 0.0000
928 PRODUCT ADHESION ISSUE 1 0.0000
929 SKIN BURNING SENSATION 2 0.0000
930 RESTLESSNESS 1 0.0000
931 DYSURIA 1 0.0000
932 INJECTION SITE MASS 1 0.0000
933 DYSGEUSIA 2 0.0000
934 EYE SWELLING 1 0.0000
935 THROMBOCYTOPENIA 3 0.0000
936 DYSARTHRIA 1 0.0000
937 DYSPNOEA EXERTIONAL 1 0.0000
938 INTESTINAL OBSTRUCTION 1 0.0000
939 ACNE 2 0.0000
940 PLASMA CELL MYELOMA 1 0.0000
941 DISEASE PROGRESSION 3 0.0000
942 DISORIENTATION 1 0.0000
943 INJECTION SITE HAEMORRHAGE 2 0.0000
944 ABORTION SPONTANEOUS 1 0.0000
945 DEVICE BREAKAGE 1 0.0000
946 DYSKINESIA 1 0.0000
947 BLINDNESS 1 0.0000
948 DEVICE LEAKAGE 1 0.0000
949 VAGINAL HAEMORRHAGE 1 0.0000
950 DEVICE DISLOCATION 1 0.0000
951 PULMONARY OEDEMA 1 0.0000
952 DEVICE ISSUE 2 0.0000
953 INCORRECT DOSE ADMINISTERED 5 0.0000
954 SKIN IRRITATION 1 0.0000
955 TINNITUS 1 0.0000
956 BREAST CANCER 2 0.0000
957 ARRHYTHMIA 1 0.0000
958 OCULAR HYPERAEMIA 1 0.0000
959 PULMONARY EMBOLISM 2 0.0000
960 BLOOD GLUCOSE DECREASED 1 0.0000
961 INTERSTITIAL LUNG DISEASE 1 0.0000
962 NERVOUSNESS 1 0.0000
963 DRUG EFFECT DECREASED 1 0.0000
964 HAEMATOCHEZIA 1 0.0000
965 TREMOR 3 0.0000
966 PANCYTOPENIA 1 0.0000
967 CONVULSION 1 0.0000
968 PRODUCT SUBSTITUTION ISSUE 1 0.0000
969 NO ADVERSE EVENT 3 0.0000
970 DEEP VEIN THROMBOSIS 1 0.0000
971 FEBRILE NEUTROPENIA 1 0.0000
972 RENAL FAILURE 2 0.0000
973 PRODUCT QUALITY ISSUE 2 0.0000
974 NEUTROPENIA 2 0.0000
975 DEVICE MALFUNCTION 1 0.0000
976 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
977 ACUTE KIDNEY INJURY 2 0.0000
978 CARDIAC FAILURE 1 0.0000
979 CARDIAC FAILURE CONGESTIVE 1 0.0000
980 PROSTATE CANCER 1 0.0000
981 CARDIAC ARREST 1 0.0000
982 MYOCARDIAL INFARCTION 2 0.0000
983 PRODUCT STORAGE ERROR 1 0.0000
984 DRUG WITHDRAWAL SYNDROME 1 0.0000
985 BLOOD GLUCOSE INCREASED 2 0.0000
986 HAEMOGLOBIN DECREASED 1 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
988 DEATH 8 0.0000
989 OVERDOSE 2 0.0000
990 SEPSIS 1 0.0000
991 DRUG DOSE OMISSION 1 0.0000